BETHKIS - (300 mg/4 ml; Solution, Inhalation)

Generic Name	Tobramycin	Innovator	Chiesi U.S.A
Dosage	300 mg/4 ml; Solution, Inhalation	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	Used to treat people with cystic fibrosis who have a bacterial infection called Pseudomonas aeruginosa
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
****	*** / ***	**** *, ****	*******	********	******** ** *** **, ****

Chronology Of Events